| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.49 | 1e-22 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-20 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-14 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.53 | 0.0009 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |